Racial and ethnic disparities exist in the rates of severe influenza-associated disease among U.S. children and adults.
Licensed and age-appropriate vaccines for influenza are recommended for the 2021 to 2022 season for all persons aged 6 months or older who do not have contraindications.
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Seasonal influenza vaccination in pregnancy is not significantly associated with adverse early childhood health outcomes among offspring.
The world’s first case of H10N3 bird flu in a person has been reported in China, but chances are low the virus will spread widely among people.
Investigators conducted a systematic review and meta-analysis of 37 studies that used a test-negative design to evaluate IVE against influenza-associated hospitalization in children.
Medicare patients of female physicians are more likely than patients of male physicians to receive the influenza vaccine.
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.